COLL Earnings

Quarterly EPS
$0.29
Q3 2024
$0.39
Q4 2024
$0.08
Q1 2025
$0.38
Q2 2025
$1.00
Q3 2025
$0.54
Q4 2025
$0.45
Q1 2026
$-0.46
Q2 2026
Latest Revenue199.9M
Latest Net Income-15051000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.46199.9M-15051000+6.3%-221.1%
Q1 2026$0.45193.5M14.5M+8.9%+462.5%
Q4 2025$0.54205.4M17.0M+12.9%+38.5%
Q3 2025$1.00209.4M31.5M+31.4%+244.8%
Q2 2025$0.38188.0M12.0M+29.4%-36.7%
Q1 2025$0.08177.8M2.4M+22.7%-90.7%
Q4 2024$0.39181.9M12.5M+21.5%-60.6%
Q3 2024$0.29159.3M9.3M+16.5%-52.5%
Q2 2024$0.60145.3M19.6M
Q1 2024$0.86144.9M27.7M
Q4 2023$0.99149.7M31.9M
Q3 2023$0.61136.7M20.6M
Collegium Pharmaceutical (COLL) — Earnings